Abstract:Abstract Background Liver cancer is among the most common malignancy worldwide. Hepatocellular carcinoma (HCC), the principal histological subtype of liver cancer, is globally the third most common cause of cancer-related mortality. The high rates of recurrence and metastasis contribute to the poor prognosis of HCC patients. In recent years, increasing evidence has shown that microRNAs (miRNAs) are involved in the tumorigenesis, progression, and prognosis of HCC. Methods To screen for key candidate miRNAs in HCC, three microarray datasets were downloaded from Gene Expression Omnibus (GEO). The sole common differentially expressed miRNA (DEmiR) observed in the above three datasets using a Venn diagram was microRNA-211-5p (miR-211-5p). The expression of miR-211-5p from HCC tissues was measured in several HCC cell lines. Additionally, using Kaplan–Meier plots, the potential prognostic value of miR-211-5p in HCC was analyzed. Cell counting kit-8 (CCK-8) and transwell assays examined the ability of miR-211-5p to induce cell proliferation, migration, and invasion in HCC cultures. The interaction of miR-211-5p and Acyl-CoA Synthetase Long Chain Family Member 4 (ACSL4) was assessed both theoretically and using a luciferase reporter assay. Finally, the ability of miR-211-5p to modulate tumorigenesis in HCC in vivo was assessed after establishing a xenograft model. Results qRT-PCR demonstrated that the relative expression of miR-211-5p was considerably down-regulated in HCC tissues and cell lines compared with normal tissue. Kaplan–Meier plots indicated that HCC patients with decreased expression of miR-211-5p had poor overall survival. Upregulation of miR-211-5p in vitro consistently suppressed cell proliferation, migration, and invasion. In contrast, enhanced expression of ACSL4 promoted a malignant phenotype in HCC cells. Importantly, we discovered that ACSL4 was a direct downstream target of miR-211-5p in HCC, and that miR-211-5p suppressed the malignant phenotype by inhibition of ACSL4 expression. Furthermore, miR-211-5p overexpression impaired tumorigenesis and growth of HCC in vivo. Conclusions Targeting miR-211-5p and the downstream gene ACSL4 will possibly provide novel insight and represents a promising approach to future therapy of HCC patients.

MicroRNA-31 Suppresses the Self-Renewal Capability of Α2δ1+ Liver Tumor-Initiating Cells by Targeting ISL1.

MiR-29a Suppresses Cell Proliferation by Targeting SIRT1 in Hepatocellular Carcinoma

miR-361-3p Regulates Liver Tumor-initiating Cells Expansion and Chemo-resistance

MicroRNA-145 Suppresses Hepatocellular Carcinoma by Targeting IRS1 and Its Downstream Akt Signaling.

MiR-875-5p suppresses Gli1 to alter the hedgehog signaling pathway, which in turn has hepatocellular cancer-related tumor suppressing properties

MicroRNA-381 Suppresses Cell Growth and Invasion by Targeting the Liver Receptor Homolog-1 in Hepatocellular Carcinoma.

Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells

Mir-31 Modulates Liver Cancer HepG2 Cell Apoptosis and Invasion Via ROCK1/F-Actin Pathways

MicroRNA-30a-5p Suppresses Proliferation, Invasion and Tumor Growth of Hepatocellular Cancer Cells Via Targeting FOXA1

MicroRNA-1 Inhibits Proliferation of Hepatocarcinoma Cells by Targeting Endothelin-1

MicroRNA‑29c‑3p Acts As a Tumor Suppressor Gene and Inhibits Tumor Progression in Hepatocellular Carcinoma by Targeting TRIM31

Microrna-29b Suppresses Tumor Angiogenesis, Invasion, and Metastasis by Regulating Matrix Metalloproteinase 2 Expression

Mir-3682-3p Directly Targets FOXO3 and Stimulates Tumor Stemness in Hepatocellular Carcinoma Via a Positive Feedback Loop Involving FOXO3/PI3K/AKT/c-Myc

MicroRNA-302a/d Inhibits the Self-Renewal Capability and Cell Cycle Entry of Liver Cancer Stem Cells by Targeting the E2F7/AKT Axis

microRNA‐2117 Negatively Regulates Liver Cancer Stem Cells Expansion and Chemoresistance Via Targeting SOX2

Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in Hepatocellular Carcinoma

MicroRNA-138 Targets SP1 to Inhibit the Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cells

MicroRNAs-491-5p Suppresses Cell Proliferation and Invasion by Inhibiting IGF2BP1 in Non-Small Cell Lung Cancer.

miR-342-3p suppresses hepatocellular carcinoma proliferation through inhibition of IGF-1R-mediated Warburg effect.

MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation.

Mir-1188 at the Imprinted Dlk1-Dio3 Domain Acts As A Tumor Suppressor in Hepatoma Cells